Bank of America estimates the potential sales of the drug remibrutinib manufactured by Novartis.
4 reports, 1 independent
Updated Sep 10
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America estimates the potential sales of the drug remibrutinib manufactured by Novartis.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Novartis
Swiss-American multinational pharmaceutical corporation